PT2264009T - Composto do ácido piridilaminoacético - Google Patents
Composto do ácido piridilaminoacéticoInfo
- Publication number
- PT2264009T PT2264009T PT09721163T PT09721163T PT2264009T PT 2264009 T PT2264009 T PT 2264009T PT 09721163 T PT09721163 T PT 09721163T PT 09721163 T PT09721163 T PT 09721163T PT 2264009 T PT2264009 T PT 2264009T
- Authority
- PT
- Portugal
- Prior art keywords
- acid compound
- pyridylaminoacetic acid
- pyridylaminoacetic
- compound
- acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008062926 | 2008-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2264009T true PT2264009T (pt) | 2019-04-29 |
Family
ID=41065261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT09721163T PT2264009T (pt) | 2008-03-12 | 2009-03-12 | Composto do ácido piridilaminoacético |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8648097B2 (pt) |
| EP (1) | EP2264009B1 (pt) |
| JP (3) | JP5136640B2 (pt) |
| KR (1) | KR101609001B1 (pt) |
| CN (2) | CN103965099A (pt) |
| AU (1) | AU2009224329B2 (pt) |
| CA (1) | CA2718393C (pt) |
| CY (1) | CY1121543T1 (pt) |
| DK (1) | DK2264009T3 (pt) |
| ES (1) | ES2718813T3 (pt) |
| HR (1) | HRP20190509T1 (pt) |
| HU (1) | HUE042839T2 (pt) |
| LT (1) | LT2264009T (pt) |
| PL (1) | PL2264009T3 (pt) |
| PT (1) | PT2264009T (pt) |
| SI (1) | SI2264009T1 (pt) |
| TR (1) | TR201904655T4 (pt) |
| WO (1) | WO2009113600A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2264009T1 (sl) | 2008-03-12 | 2019-05-31 | Ube Industries, Ltd. | Spojina piridilaminoocetne kisline |
| SI2415763T1 (sl) | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
| CN102548985A (zh) * | 2009-09-11 | 2012-07-04 | 宇部兴产株式会社 | 取代羰基化合物 |
| WO2011030873A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | ベンジル化合物 |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| CA2773997A1 (en) * | 2009-09-11 | 2011-03-17 | Ube Industries, Ltd. | Aniline compound |
| WO2011030865A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | 置換ベンジル化合物 |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | N-置換ヘテロアリール化合物 |
| WO2011030872A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | スルホンアミド化合物 |
| CN102666490A (zh) * | 2009-12-25 | 2012-09-12 | 宇部兴产株式会社 | 氨基吡啶化合物 |
| KR101409137B1 (ko) | 2010-03-12 | 2014-06-17 | 닛뽕소다 가부시키가이샤 | 피리딘 고리 함유 화합물, 및 할로겐화피콜린 유도체 및 테트라졸릴옥심 유도체의 제조 방법 |
| EP2547204A2 (de) * | 2010-03-18 | 2013-01-23 | Bayer Intellectual Property GmbH | Aryl- und hetarylsulfonamide als wirkstoffe gegen abiotischen pflanzenstress |
| EP2471363A1 (de) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen |
| JPWO2014157672A1 (ja) * | 2013-03-28 | 2017-02-16 | 宇部興産株式会社 | 置換ビアリール化合物 |
| KR20160047576A (ko) * | 2013-09-02 | 2016-05-02 | 우베 고산 가부시키가이샤 | 폐질환의 치료 및/또는 예방을 위한 의약 조성물 |
| WO2015105135A1 (ja) | 2014-01-10 | 2015-07-16 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物含有医薬組成物 |
| WO2015105144A1 (ja) * | 2014-01-10 | 2015-07-16 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含む医薬製剤 |
| GEAP201814216A (en) | 2014-01-10 | 2018-07-25 | Santen Pharmaceutical Co Ltd | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| CA2951790C (en) * | 2014-06-10 | 2022-05-31 | Ube Industries, Ltd. | Method for producing heteroaromatic sulfonamide compound |
| US10774072B2 (en) | 2014-06-10 | 2020-09-15 | Ube Industries, Ltd. | Crystal of N-substituted sulfonamide compound |
| US10428046B2 (en) | 2014-06-10 | 2019-10-01 | Ube Industries, Ltd. | N-substituted sulfonamide compound and method for producing same |
| JP2017206445A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 呼吸器疾患の治療及び/又は予防のための医薬組成物 |
| JP2017206443A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 置換ビアリール化合物及び他の医薬の組み合わせ |
| WO2017006985A1 (ja) | 2015-07-09 | 2017-01-12 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する予防及び/又は治療剤 |
| WO2018108627A1 (de) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen |
| WO2019025153A1 (de) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen |
| US10940144B2 (en) | 2017-09-29 | 2021-03-09 | Santen Pharmaceutical Co., Ltd. | Drug containing pyridylaminoacetic acid compound |
| US20210106569A1 (en) | 2017-12-21 | 2021-04-15 | Santen Pharmaceutical Co., Ltd. | Omidenepag combination |
| CN111526876A (zh) | 2017-12-28 | 2020-08-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
| CN118084895B (zh) * | 2024-02-28 | 2025-09-05 | 中国药科大学 | 一种一氧化氮供体型Omidenepag衍生物及其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991019300A1 (en) | 1990-06-08 | 1991-12-12 | Sps Technologies, Incorporated | Improved magnetic materials and process for producing the same |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| AP2000001889A0 (en) | 1998-01-27 | 2000-09-30 | Aventis Pharm Prod Inc | Substituted ozoazaheterocyclyl factor Xa inhibitors. |
| AU2001290250A1 (en) | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| WO2003016254A1 (en) * | 2001-08-09 | 2003-02-27 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| AU2001297521B2 (en) | 2001-10-26 | 2007-10-04 | Allergan, Inc. | Co-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| OA12760A (en) | 2002-01-31 | 2006-07-04 | Pfizer Prod Inc | Metabolites of (3-ÄÄ4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-aminoÜ-methylÜ-phenoxy)-acetic acid. |
| CA2477715A1 (en) * | 2002-03-05 | 2003-09-12 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| KR20050105511A (ko) | 2003-03-04 | 2005-11-04 | 화이자 프로덕츠 인크. | 의학적 치료에서 ep2 선택적 수용체 효능제의 용도 |
| GB0329620D0 (en) | 2003-12-22 | 2004-01-28 | Pharmagene Lab Ltd | EP2 receptor agonists |
| JP2007186424A (ja) | 2004-11-26 | 2007-07-26 | Ono Pharmaceut Co Ltd | 気管支拡張剤 |
| WO2005072743A1 (ja) | 2004-01-30 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 気管支拡張剤 |
| JP4734119B2 (ja) | 2004-02-12 | 2011-07-27 | 田辺三菱製薬株式会社 | インダゾール化合物及びその医薬用途 |
| EP1593671A1 (en) | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
| JP2008503490A (ja) | 2004-06-17 | 2008-02-07 | センジェント・セラピューティクス・インコーポレイテッド | チロシンホスファターゼの三置換窒素調節物質 |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| CA2593439C (en) | 2005-01-14 | 2014-02-25 | F. Hoffmann-La Roche Ag | Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| WO2006106711A1 (ja) | 2005-03-30 | 2006-10-12 | Eisai R & D Management Co., Ltd. | ピリジン誘導体を含有する抗真菌剤 |
| EP1912957A4 (en) | 2005-08-03 | 2009-05-13 | Merck Frosst Canada Ltd | EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS |
| US8080567B2 (en) * | 2005-08-09 | 2011-12-20 | Asterand Uk Limited | EP2 receptor agonists |
| US7696235B2 (en) * | 2005-08-29 | 2010-04-13 | Allergan, Inc. | EP2 receptor agonists for treating glaucoma |
| CA2659184C (en) * | 2006-07-28 | 2012-02-21 | Pfizer Products Inc. | Ep2 agonists |
| UA94953C2 (en) * | 2006-07-28 | 2011-06-25 | Пфайзер Продактс Инк. | Ep2 agonists |
| SI2264009T1 (sl) | 2008-03-12 | 2019-05-31 | Ube Industries, Ltd. | Spojina piridilaminoocetne kisline |
| SI2415763T1 (sl) * | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
-
2009
- 2009-03-12 SI SI200931953T patent/SI2264009T1/sl unknown
- 2009-03-12 CA CA2718393A patent/CA2718393C/en active Active
- 2009-03-12 CN CN201410213200.5A patent/CN103965099A/zh active Pending
- 2009-03-12 HR HRP20190509TT patent/HRP20190509T1/hr unknown
- 2009-03-12 TR TR2019/04655T patent/TR201904655T4/tr unknown
- 2009-03-12 EP EP09721163.5A patent/EP2264009B1/en active Active
- 2009-03-12 DK DK09721163.5T patent/DK2264009T3/en active
- 2009-03-12 PT PT09721163T patent/PT2264009T/pt unknown
- 2009-03-12 US US12/922,028 patent/US8648097B2/en active Active
- 2009-03-12 JP JP2010502864A patent/JP5136640B2/ja active Active
- 2009-03-12 CN CN200980108500.4A patent/CN101970410B/zh active Active
- 2009-03-12 PL PL09721163T patent/PL2264009T3/pl unknown
- 2009-03-12 ES ES09721163T patent/ES2718813T3/es active Active
- 2009-03-12 WO PCT/JP2009/054713 patent/WO2009113600A1/ja not_active Ceased
- 2009-03-12 LT LTEP09721163.5T patent/LT2264009T/lt unknown
- 2009-03-12 AU AU2009224329A patent/AU2009224329B2/en active Active
- 2009-03-12 HU HUE09721163A patent/HUE042839T2/hu unknown
- 2009-03-12 KR KR1020107022680A patent/KR101609001B1/ko active Active
-
2012
- 2012-11-15 JP JP2012251011A patent/JP5545344B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-16 US US14/108,029 patent/US20140113907A1/en not_active Abandoned
-
2014
- 2014-05-14 JP JP2014100287A patent/JP2014177476A/ja active Pending
-
2019
- 2019-03-28 CY CY20191100359T patent/CY1121543T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2718393A1 (en) | 2009-09-17 |
| US20140113907A1 (en) | 2014-04-24 |
| HRP20190509T1 (hr) | 2019-05-03 |
| CN101970410B (zh) | 2014-06-25 |
| AU2009224329B2 (en) | 2013-11-07 |
| JP5136640B2 (ja) | 2013-02-06 |
| JP5545344B2 (ja) | 2014-07-09 |
| CN101970410A (zh) | 2011-02-09 |
| US20110054172A1 (en) | 2011-03-03 |
| CN103965099A (zh) | 2014-08-06 |
| EP2264009B1 (en) | 2019-03-06 |
| AU2009224329A1 (en) | 2009-09-17 |
| EP2264009A4 (en) | 2012-08-01 |
| KR101609001B1 (ko) | 2016-04-04 |
| TR201904655T4 (tr) | 2019-06-21 |
| WO2009113600A1 (ja) | 2009-09-17 |
| LT2264009T (lt) | 2019-04-25 |
| JP2014177476A (ja) | 2014-09-25 |
| JPWO2009113600A1 (ja) | 2011-07-21 |
| CY1121543T1 (el) | 2020-05-29 |
| ES2718813T3 (es) | 2019-07-04 |
| CA2718393C (en) | 2015-06-16 |
| JP2013063994A (ja) | 2013-04-11 |
| PL2264009T3 (pl) | 2019-07-31 |
| DK2264009T3 (en) | 2019-04-15 |
| EP2264009A1 (en) | 2010-12-22 |
| US8648097B2 (en) | 2014-02-11 |
| KR20100123903A (ko) | 2010-11-25 |
| SI2264009T1 (sl) | 2019-05-31 |
| HUE042839T2 (hu) | 2019-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2264009T (lt) | Piridilaminoacto rūgšties junginys | |
| ZA201008096B (en) | Carboxylic acid compound | |
| GB0818033D0 (en) | Novel compound | |
| SI2192109T1 (sl) | Biciklični aminokislinski derivati | |
| GB0800035D0 (en) | Compounds | |
| GB0804989D0 (en) | Compound | |
| ZA201000869B (en) | Phenylacetic acid compound | |
| GB0803494D0 (en) | Compound | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
| GB0800367D0 (en) | Compounds | |
| GB0823316D0 (en) | Compound | |
| GB0801220D0 (en) | Compounds | |
| GB0801265D0 (en) | Compounds | |
| GB0820919D0 (en) | Compound | |
| GB0820915D0 (en) | Compound | |
| GB0807158D0 (en) | Compound | |
| GB0815806D0 (en) | Compound | |
| GB0802193D0 (en) | Compound | |
| GB0820249D0 (en) | Compound | |
| GB0805430D0 (en) | Compound | |
| GB0822635D0 (en) | Compound | |
| GB0820918D0 (en) | Compound | |
| GB0802227D0 (en) | Compound | |
| GB0806844D0 (en) | Compound |